Ayana Bio: CEO spotlights promising partnership to develop plant cell-derived saffron
06 Feb 2024 | Ayana Bio
We sit down with Frank Jaksch, CEO of Ayana Bio, to go into the details of the joint development agreement the company recently signed with Wooree Green Science, aiming to develop plant cell-derived saffron and other bioactive ingredients for health and wellness products for the South Korean market. Jaksch highlights the agreement’s primary goals to increase the accessibility and affordability of saffron to support product development.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa

















